Lundbeck Welcomes Revised Nice Recommendations For Alzheimer's Disease Treatments
Links shared publicly online about this topic.
- 420total visits
Lundbeck Welcomes Revised Nice Recommendations For Alzheimer's Disease Treatments
Lundbeck, the maker of Ebixa® (memantine), welcomes the publication of final guidance on drug treatment for all stages of Alzheimer's disease (AD) by the National Institute for Health and Clin
View full resource at medicalnewstoday.com
Tags: Alzheimer's Disease, Alzheimer's Disease Medication, Disease and Condition, Drug, Namenda, Axura, disease
Most Recently Shared on March 23, 2011 at 3:33 pm By:
Lundbeck Welcomes Revised Nice Recommendations For Alzheimer's Disease Treatments http://t.co/iv6gWEb via @mnt_alzheimers
Also Shared By:
NICE Set To Make Significant Revisions To Treatment Guidelines Providing Welcome News For People With Alzheimer's Disease
medicalnewstoday.com — “The National Institute for Health and Clinical Excellence (NICE) has published draft guidance that makes substantial revisions to recommendations for the treatment of Alzheimer's disease (AD). T” View full resource at medicalnewstoday.com
Most Recently Shared on October 8, 2010 at 12:05 pm By:
MNT Alzheimer's News Health News
NICE Set To Make Significant Revisions To Treatment Guidelines Providing Welcome News For People With Alzheimer's Disease http://mnt.to/3KRx
Advertisement
MedicalFeed
@MedicalFeed
Lundbeck Welcomes Revised Nice Recommendations For Alzheimer's Disease Treatments: Lundbeck… http://goo.gl/fb/rdY1k
1 year ago...